Information for Industry

Revised: 8 May 2012

Vigilance

Pharmacovigilance

Post market surveilance of medicines.

Pharmacovigilance Guideline

Part 8: Pharmacovigilance Edition 2.0 (PDF 258 KB, 36 pages)

MedicalDevice Adverse Event Reporting

Post market surveilance of medical devices.